{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:52:53Z","timestamp":1790855573745,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.semarthrit.2020.10.003","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T17:13:28Z","timestamp":1608225208000},"page":"20-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Beta-2-glycoprotein-I IgA antibodies predict coronary plaque progression in rheumatoid arthritis"],"prefix":"10.1016","volume":"51","author":[{"given":"George A.","family":"Karpouzas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Ormseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viet L.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2020.10.003_bib0001","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1136\/annrheumdis-2013-203617","article-title":"Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease","volume":"73","author":"Karpouzas","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0002","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study","volume":"10","author":"Naranjo","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0003","first-page":"937","article-title":"Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis","volume":"34","author":"Aubry","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0004","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.99.17.2227","article-title":"Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression","volume":"99","author":"George","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2004.04.027","article-title":"Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques","volume":"176","author":"Yilmaz","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0006","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1191\/096120300678828262","article-title":"Accelerated atheroma and anti-beta2-glycoprotein I antibodies","volume":"9","author":"Matsuura","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0007","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/01.CIR.98.11.1108","article-title":"Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I","volume":"98","author":"George","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0008","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000028046","article-title":"Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice","volume":"67","author":"Afek","year":"1999","journal-title":"Pathobiology"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0009","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1568-9972(02)00084-8","article-title":"Autoantibody-mediated atherosclerosis","volume":"1","author":"Matsuura","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaut.2006.09.007","article-title":"Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of beta2-GPI","volume":"27","author":"Iverson","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0011","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1196\/annals.1422.049","article-title":"Antiphospholipid antibodies in patients with coronary artery disease: new cardiac risk factors?","volume":"1108","author":"Greco","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0012","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00011-013-0652-x","article-title":"Antiphospholipid antibodies and sub-clinical atherosclerosis in the Coronary Artery Risk Development in Young Adults (CARDIA) cohort","volume":"62","author":"Majka","year":"2013","journal-title":"Inflamm Res"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0013","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.autrev.2006.06.014","article-title":"IgA antibodies to beta2-glycoprotein I and atherosclerosis","volume":"6","author":"Staub","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0014","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jbspin.2008.01.022","article-title":"Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis","volume":"75","author":"Pereira","year":"2008","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0015","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.imbio.2006.01.004","article-title":"Antiphospholipid antibodies as a possible risk factor for atherosclerosis in patients with rheumatoid arthritis","volume":"211","author":"Pahor","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0016","doi-asserted-by":"crossref","first-page":"e23217","DOI":"10.1002\/jcla.23217","article-title":"IgA is the predominant isotype of anti-\u03b22 glycoprotein I antibodies in rheumatoid arthritis","author":"Melayah","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0017","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.imbio.2011.05.008","article-title":"Antiphospholipid antibodies and atherosclerosis: insights from rheumatoid arthritis \u2013 a five-year follow-up study","volume":"216","author":"Holc","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0018","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jcmg.2018.04.015","article-title":"Effects of statins on coronary atherosclerotic plaques: the PARADIGM Study","volume":"11","author":"Lee","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0019","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0020","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/art.41122","article-title":"Impact of cumulative inflammation, cardiac risk factors and medication exposure on coronary atherosclerosis progression in rheumatoid arthritis","volume":"72","author":"Karpouzas","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0021","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0022","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jcct.2014.07.003","article-title":"SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee","volume":"8","author":"Leipsic","year":"2014","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0023","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCIMAGING.113.001047","article-title":"Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events","volume":"7","author":"Bittencourt","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0024","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jcct.2010.05.018","article-title":"Interobserver variations of plaque severity score and segment stenosis score in coronary arteries using 64 slice multidetector computed tomography: a substudy of the ACCURACY trial","volume":"4","author":"Pagali","year":"2010","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177175","article-title":"Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables","volume":"12","author":"Swainson","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0026","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0027","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/CIRCULATIONAHA.106.674143","article-title":"Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"115","author":"Kronmal","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0028","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0029","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12016-008-8096-8","article-title":"Immunogenic oxidized low-density lipoprotein\/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis","volume":"37","author":"Lopez","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0031","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12026-016-8812-z","article-title":"Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome","volume":"65","author":"Nuri","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0032","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10554-010-9625-0","article-title":"Variation in atherosclerotic plaque composition according to increasing coronary artery calcium scores on computed tomography angiography","volume":"26","author":"Nasir","year":"2010","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2020.02.016","article-title":"Innate and adaptive immunity in cardiovascular calcification","author":"Passos","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0034","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","article-title":"Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions","volume":"20","author":"Virmani","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcin.2008.01.007","article-title":"Head-to-head comparison of coronary plaque evaluation between multislice computed tomography and intravascular ultrasound radiofrequency data analysis","volume":"1","author":"Pundziute","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0036","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1161\/CIRCULATIONAHA.107.732867","article-title":"Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo","volume":"116","author":"Aikawa","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0037","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s12350-011-9428-2","article-title":"Comprehensive assessment of spotty calcifications on computed tomography angiography: comparison to plaque characteristics on intravascular ultrasound with radiofrequency backscatter analysis","volume":"18","author":"van Velzen","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0038","doi-asserted-by":"crossref","first-page":"43","DOI":"10.17219\/acem\/29847","article-title":"Disease activity, oxidized-LDL fraction and anti-oxidized LDL antibodies influence cardiovascular risk in rheumatoid arthritis","volume":"25","author":"Nowak","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0039","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.ATV.20.6.1536","article-title":"Infection and inflammation induce LDL oxidation in vivo","volume":"20","author":"Memon","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0040","first-page":"55","article-title":"IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus","volume":"318","author":"Cucurull","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0041","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/0961203308093460","article-title":"IgA antiphospholipid antibodies are an independent risk factor for thromboses","volume":"17","author":"Shen","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0042","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0021-9150(88)90204-3","article-title":"Association of serum IgA and C4 with severe atherosclerosis","volume":"74","author":"Muscari","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0043","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1097\/TP.0000000000001062","article-title":"Prevalence of IgA antibodies to \u03b22-glycoprotein I: a population-dependent feature?","volume":"100","author":"Visentin","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.semarthrit.2020.10.003_bib0044","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(15)60291-4","article-title":"CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial","volume":"385","year":"2015","journal-title":"Lancet"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722030295X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901722030295X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:03:12Z","timestamp":1758733392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901722030295X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S004901722030295X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.10.003","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-2-glycoprotein-I IgA antibodies predict coronary plaque progression in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}